LRM Aesthetics, a wholly owned subsidiary of Lynch Regenerative Medicine, is proud to offer our first product, ariessence pure PDGF+ a cutting-edge topical solution for skin rejuvenation. It offers providers a quick, easy to use, consistent, and trusted approach to post-procedure skin rejuvenation, while giving clients joy and confidence through the appearance of healthier, more vibrant skin. Please visit us at ariessence.com to learn all about our incredible product.
Addressing a $100 billion market opportunity in skin rejuvenation (aesthetics) and regeneration (healing).
​
Multiple product opportunities in each skin aesthetic and healing indications.
​
Proven leadership has created over $1 B in value in regenerative medicine space.
​
Proven, proprietary technology based on the body’s own healing protein already FDA approved in other indications.
Valuations of companies in similar markets trading at 16X revenue.
​
Compelling growth strategy to minimize risk and maximize return by building core capabilities that serve both aesthetics and healing indications.
A New, Advanced Skin Care Company Poised to Address Major, Underserved Skin Conditions
~ $100+ billion is spent annually today to regenerate and rejuvenate skin
Aesthetics
Markets are vast and largely underserved with differentiated solutions.
$61 billion spent on treatment annually.
​
Chronic Wounds
6 million US patients
-
Diabetic Ulcers (2.5M)
-
Pressure Ulcers (2.5M)
-
Other (1M+)
​
$25 billion spent on treatment annually in the US
Acute Wounds
Over 35 million US patients
-
Post Surgical (30M)
-
Trauma (2.5M)
-
Burns (750k)
​
$11 billion spent on treatment annually in the US
Regenerative Impact
rhPDGF delivered from a needle tip (dark shadow entering from the left side of the video) attracts the patient's regenerative stem cells!
​
rhPDGF attracts and stimulates YOUR OWN stem cells to power natural skin rejuvenation and regeneration. ​
​
rhPDGF may help patients achieve healthier, more attractive and better feeling skin.